Insider Transactions in Q1 2024 at C4 Therapeutics, Inc. (CCCC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2024
|
Andrew Hirsch President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,560
-3.02%
|
$45,920
$7.9 P/Share
|
|
Feb 14
2024
|
Mark Mossler Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,290
+48.03%
|
-
|
|
Feb 14
2024
|
Kelly Schick Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,300
+34.32%
|
-
|
|
Feb 14
2024
|
Jolie Siegel Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,300
+34.32%
|
-
|
|
Feb 14
2024
|
Leonard Reyno Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,700
+27.25%
|
-
|
|
Feb 14
2024
|
Andrew Hirsch President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
103,400
+32.24%
|
-
|
|
Feb 14
2024
|
Kendra Adams Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,700
+30.91%
|
-
|
|
Feb 14
2024
|
Scott N Boyle Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,300
+34.28%
|
-
|
|
Feb 14
2024
|
Stewart Fisher Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,300
+17.45%
|
-
|
|
Feb 13
2024
|
Kelly Schick Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,735
-6.5%
|
$10,410
$6.53 P/Share
|
|
Feb 13
2024
|
Jolie Siegel Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,735
-6.5%
|
$10,410
$6.53 P/Share
|
|
Feb 13
2024
|
Kendra Adams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,301
-2.79%
|
$7,806
$6.53 P/Share
|
|
Feb 13
2024
|
Scott N Boyle Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,735
-6.48%
|
$10,410
$6.53 P/Share
|
|
Feb 13
2024
|
Stewart Fisher Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,255
-2.17%
|
$13,530
$6.53 P/Share
|
|
Jan 02
2024
|
Donna Roy Grogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,108
+8.77%
|
$12,648
$6.52 P/Share
|
|
Jan 02
2024
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,725
+1.53%
|
$10,350
$6.52 P/Share
|
|
Jan 02
2024
|
Glenn Dubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,687
+7.53%
|
$10,122
$6.52 P/Share
|